Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy
The DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
The application of nanoparticles for the delivery and targeting of pharmaceutical, therapeutic and diagnostic agents in cancer therapy has received significant attention in recent years. Nanoparticles may be constructed from a wide range of materials and used to encapsulate or solubilize chemotherapeutic agents for improved delivery in vivo or to provide unique optical, magnetic and electrical properties for imaging and therapy. Several functional nanoparticles have already been demonstrated, including some clinically approved liposome drug formulations and metallic imaging agents. The next generation of nanoparticle-based research is directed at the consolidation of functions into strategically engineered multifunctional systems, which may ultimately facilitate the realization of individual therapy. These multiplexed nanoparticles may be capable of identifying malignant cells by means of molecular detection, visualizing their location in the body by providing enhanced contrast in medical imaging techniques, killing diseased cells with minimal side effects through selective drug targeting, and monitoring treatment in real time. This article highlights recent progress in the design and engineering of multifunctional systems, as well as discusses the development of a new, scalable and economic method for the modular preparation of multiplex nanoparticles where functional properties can be precisely and simply tailored.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In flash precipitation, an aqueous and organic phase are mixed rapidly with engineered geometries in a special “jet mixer” instrument which allows for the synthesis of uniform nanoparticles [266, 267]. This process has been brought to scale by BASF for the generation of β-carotene nanoparticles [268].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [268]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 102 · Cited by 298
Research works printed but not linked: 8
- Kataoka, 2000, J Colloid Interface Sci, 64, 143
- Couvreur, 1995, Eur J Pharm Biopharm, 41, 2
- Karabutova, 2003, Laser Phys, 13, 711
- Taylor, 1983, Federation Proc, 42, 2440
- Winter, 2003, Cancer Res, 63, 5838
- Yuan, 1995, Cancer Res, 55, 3752
- Langer, 1998, Nature, 392, 5
- Baselga, 1998, Cancer Res, 58, 2825
Metadata
- Authors
- Gindy, M. E., & Prud'homme, R. K.
- Affiliations
- Princeton University (US)
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2009-07-28
- Volume
- 6
- Issue
- 8
- Pages
- 865-878
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W1985969082
- Cited by
- 298
- References
- 102
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 19 · 2023: 15 · 2022: 11 · 2021: 14 · 2020: 14 · 2019: 14 · 2018: 22 · 2017: 13 · 2016: 19 · 2015: 18 · 2014: 30 · 2013: 22 · 2012: 18
- FWCI
- 10.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Opinion on Drug Delivery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- multifunctional nanoparticles, cancer therapy, drug delivery, targeted drug delivery, tumor imaging, liposomes, theranostics, anticancer agents, treatment monitoring
- MeSH terms
- Antineoplastic Agents, Diagnostic Imaging, Drug Carriers, Humans, Neoplasms, Biomarkers, Tumor, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy. https://app.cochat.ai/papers/10.1517/17425240902932908
- The paper
- Gindy, M. E., & Prud'homme, R. K. (2009). Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy. Expert Opinion on Drug Delivery. https://doi.org/10.1517/17425240902932908
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.